HoyleCohen’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,147
| Closed | -$401K | – | 294 |
|
|
2024
Q1 | $401K | Buy |
4,147
+229
| +6% | +$22.2K | 0.03% | 213 |
|
|
2023
Q4 | $396K | Hold |
3,918
| – | – | 0.03% | 210 |
|
|
2023
Q3 | $399K | Buy |
3,918
+225
| +6% | +$22.9K | 0.04% | 196 |
|
|
2023
Q2 | $373K | Hold |
3,693
| – | – | 0.03% | 203 |
|
|
2023
Q1 | $340K | Sell |
3,693
-1,000
| -21% | -$92K | 0.03% | 209 |
|
|
2022
Q4 | $426K | Sell |
4,693
-467
| -9% | -$42.4K | 0.04% | 195 |
|
|
2022
Q3 | $392K | Sell |
5,160
-99
| -2% | -$7.52K | 0.04% | 190 |
|
|
2022
Q2 | $445K | Sell |
5,259
-94
| -2% | -$7.95K | 0.05% | 184 |
|
|
2022
Q1 | $470K | Sell |
5,353
-220
| -4% | -$19.3K | 0.04% | 193 |
|
|
2021
Q4 | $487K | Buy |
5,573
+651
| +13% | +$56.9K | 0.04% | 195 |
|
|
2021
Q3 | $403K | Hold |
4,922
| – | – | 0.04% | 198 |
|
|
2021
Q2 | $449 | Sell |
4,922
-15
| -0.3% | -$1 | 0.04% | 192 |
|
|
2021
Q1 | $422K | Sell |
4,937
-185
| -4% | -$15.8K | 0.04% | 191 |
|
|
2020
Q4 | $484K | Sell |
5,122
-150
| -3% | -$14.2K | 0.06% | 165 |
|
|
2020
Q3 | $458K | Buy |
5,272
+200
| +4% | +$17.4K | 0.07% | 142 |
|
|
2020
Q2 | $443K | Hold |
5,072
| – | – | 0.07% | 131 |
|
|
2020
Q1 | $418K | Sell |
5,072
-40
| -0.8% | -$3.3K | 0.08% | 132 |
|
|
2019
Q4 | $484K | Hold |
5,112
| – | – | 0.08% | 141 |
|
|
2019
Q3 | $444K | Hold |
5,112
| – | – | 0.08% | 147 |
|
|
2019
Q2 | $467K | Buy |
5,112
+1,779
| +53% | +$163K | 0.08% | 141 |
|
|
2019
Q1 | $287K | Buy |
3,333
+687
| +26% | +$59.2K | 0.05% | 157 |
|
|
2018
Q4 | $203K | Hold |
2,646
| – | – | 0.04% | 161 |
|
|
2018
Q3 | $204K | Buy |
+2,646
| New | +$204K | 0.04% | 163 |
|
|
2018
Q2 | – | Sell |
-3,316
| Closed | -$240K | – | 163 |
|
|
2018
Q1 | $240K | Sell |
3,316
-237
| -7% | -$17.2K | 0.05% | 142 |
|
|
2017
Q4 | $267K | Buy |
+3,553
| New | +$267K | 0.05% | 139 |
|